Egis Heads for Three-Year Low as Tradewinds Global Sells Shares

Egis Gyogyszergyar Nyrt. (EGIS), a Hungarian drugmaker owned by Laboratoires Servier, headed for the lowest in three years after saying that Tradewinds Global Investors LLC cut its stake in the company to below 5 percent.

The shares dropped 0.8 percent to 13,865 forint by 10:09 a.m. in Budapest, the lowest on a closing basis since May 2009. Los Angeles-based Tradewinds’ stake in the company dropped below 10 percent in March, according to an earlier statement.

To contact the reporter on this story: Andras Gergely in Budapest at agergely@bloomberg.net

To contact the editor responsible for this story: Gavin Serkin at gserkin@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.